대한임상독성학회지 (Journal of The Korean Society of Clinical Toxicology)

  • 제21권1호
  • /
  • Pages.56-63
  • /
  • 2023
  • /
  • 1738-1320(pISSN)
  • /
  • 2508-6332(eISSN)
대한임상독성학회 (Korean society of Clincal Toxicology)
권호 표지
DOI QR코드

DOI QR Code

프로프라놀롤 혈중 농도에 따른 중독환자의 임상 양상 분석

Poisoning patients' clinical features according to the blood level of propranolol

  • 김승현 (가톨릭대학교 의과대학 응급의학교실) ;
  • 소병학 (가톨릭대학교 의과대학 응급의학교실) ;
  • 김형민 (가톨릭대학교 의과대학 응급의학교실) ;
  • 차경만 (가톨릭대학교 의과대학 응급의학교실) ;
  • 송환 (가톨릭대학교 의과대학 응급의학교실) ;
  • 정원중 (가톨릭대학교 의과대학 응급의학교실)
  • Sungheon Kim (Department of Emergency Medicine, College of Medicine, The Catholic University of Korea) ;
  • Byung Hak So (Department of Emergency Medicine, College of Medicine, The Catholic University of Korea) ;
  • Hyung Min Kim (Department of Emergency Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kyeong Man Cha (Department of Emergency Medicine, College of Medicine, The Catholic University of Korea) ;
  • Hwan Song (Department of Emergency Medicine, College of Medicine, The Catholic University of Korea) ;
  • Won Jung Jeong (Department of Emergency Medicine, College of Medicine, The Catholic University of Korea)
  • 투고 : 2023.06.16
  • 심사 : 2023.06.21
  • 발행 : 2023.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Propranolol is widely prescribed to psychiatric patients to control adrenergic symptoms. However, propranolol poisoning can be fatal due to cardiovascular complications. We analyzed associations between blood levels of propranolol and patients' clinical features, with the aim of predicting progression to severe complications. Methods: Data were collected from patients aged 18 years or older who presented to the emergency department with propranolol poisoning between January 2016 and May 2022. We retrospectively analyzed their medical records and compared blood levels of propranolol between those who had cardiovascular complications and those who did not. Results: Two hundred patients were included in this study. The blood levels of propranolol were significantly higher in patients with hypotension, bradycardia, and prolonged QT intervals, with median values of 247.0 ng/mL (interquartile range [IQR], 56.5-333.8 ng/mL), 275.8 ng/mL (IQR, 154.3-486.4 ng/mL), and 159.0 ng/mL (IQR, 33.9-310.8 ng/mL), respectively. In the predictive analysis of cardiovascular complications using a receiver operating characteristic curve, the area under the curve was 0.729 with a cut-off value of 72.40 ng/mL (sensitivity, 0.667; specificity, 0.819). In addition, the correlation coefficient between blood levels and the amount of drug described during the history-taking at the time of presentation was 0.634, and this value means a relatively high relationship between the two variables. Conclusion: Because blood levels of propranolol can be used as predictors of exacerbation in patients with propranolol poisoning, patients with blood levels above 72.40 ng/mL require careful treatment and observation from their initial presentation at the emergency department.

키워드

참고문헌

  1. Cruickshank JM. Are we misunderstanding beta-blockers. Int J Cardiol 2007;120:10-27. https://doi.org/10.1016/j.ijcard.2007.01.069
  2. MeIntyre RS. β-Adrenergic receptor antagonists. In: Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry. 11th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2014. p. 933-5.
  3. Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A. Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis. J Psychopharmacol 2016;30:128-39. https://doi.org/10.1177/0269881115612236
  4. Das M. Panic disorder: propranolol and behavioural therapy. BMJ 2006;332:1094. https://doi.org/10.1136/bmj.332.7549.1094
  5. Hawton K, Casanas I Comabella C, Haw C, Saunders K. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord 2013;147:17-28. https://doi.org/10.1016/j.jad.2013.01.004
  6. Wax PM, Erdman AR, Chyka PA, Keyes DC, Caravati EM, Booze L, et al. Beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2005;43:131-46. https://doi.org/10.1081/clt200062475
  7. Snook CP, Sigvaldason K, Kristinsson J. Severe atenolol and diltiazem overdose. J Toxicol Clin Toxicol 2000;38:661-5. https://doi.org/10.1081/clt-100102018
  8. Graudins A, Lee HM, Druda D. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol 2016;81:453-61. https://doi.org/10.1111/bcp.12763
  9. Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. Highdose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol (Phila) 2011;49:277-83. https://doi.org/10.3109/15563650.2011.582471
  10. Brubacher JR. β-Adrenergic antagonists. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. Goldfrank's toxicologic emergencies. 11th ed. New York (NY): McGraw-Hill; 2019. p. 926-33.
  11. Joo SW, Min YG, Choi SC, Park EJ. The intoxication of beta blocker with psychiatric drugs focused on the cardiovascular adverse effects. J Korean Soc Clin Toxicol 2016;14:100-6. https://doi.org/10.22537/jksct.2016.14.2.100
  12. Peet M. The treatment of anxiety with beta-blocking drugs. Postgrad Med J 1988;64 Suppl 2:45-9.
  13. Laverdure B, Boulenger JP. Beta-blocking drugs and anxiety: a proven therapeutic value. Encephale 1991;17:481-92.
  14. Love JN, Howell JM, Litovitz TL, Klein-Schwartz W. Acute beta blocker overdose: factors associated with the development of cardiovascular morbidity. J Toxicol Clin Toxicol 2000; 38:275-81. https://doi.org/10.1081/clt-100100932
  15. Love JN, Enlow B, Howell JM, Klein-Schwartz W, Litovitz TL. Electrocardiographic changes associated with beta-blocker toxicity. Ann Emerg Med 2002;40:603-10. https://doi.org/10.1067/mem.2002.129829
  16. Reith DM, Dawson AH, Epid D, Whyte IM, Buckley NA, Sayer GP. Relative toxicity of beta blockers in overdose. J Toxicol Clin Toxicol 1996;34:273-8. https://doi.org/10.3109/15563659609013789
  17. Chen TW, Huang TP, Yang WC, Hong CY. Propranolol intoxication: three cases' experiences. Vet Hum Toxicol 1985;27:528-30.
  18. Ducret F, Zech P, Perrot D, Moskovtchenko JF, Traeger J. Deliberate self-overdose with propranolol: changes in serum levels (author's transl). Nouv Presse Med 1978;7:27-8.
  19. Fisher ES, Curry SC. Evaluation and treatment of acetaminophen toxicity. Adv Pharmacol 2019;85:263-72. https://doi.org/10.1016/bs.apha.2018.12.004
  20. Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol (Phila) 2012;50:91-8. https://doi.org/10.3109/15563650.2012.659252
  21. Perrone J. Iron. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. Toxicologic emergencies. 11th ed. New York (NY): McGraw-Hill; 2019. p. 669-74.
  22. Carlsson M, Cortes D, Jepsen S, Kanstrup T. Severe iron intoxication treated with exchange transfusion. Arch Dis Child 2008;93:321-2. https://doi.org/10.1136/adc.2007.123240
  23. Madiwale T, Liebelt E. Iron: not a benign therapeutic drug. Curr Opin Pediatr 2006;18:174-9. https://doi.org/10.1097/01.mop.0000193275.62366.98
  24. Adinoff B, Bone GH, Linnoila M. Acute ethanol poisoning and the ethanol withdrawal syndrome. Med Toxicol Adverse Drug Exp 1988;3:172-96. https://doi.org/10.1007/BF03259881
  25. Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol (Phila) 2010;48:1-27. https://doi.org/10.3109/15563650903544124
  26. Frishman W. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. Am Heart J 1979;97:663-70. https://doi.org/10.1016/0002-8703(79)90195-9
  27. Halloran TJ, Phillips CE. Propranolol intoxication: a severe case responding to norepinephrine therapy. Arch Intern Med 1981;141:810-1. https://doi.org/10.1001/archinte.141.6.810
  28. Hong CY, Yang WC, Chiang BN. Importance of membrane stabilizing effect in massive overdose of propranolol: plasma level study in a fatal case. Hum Toxicol 1983;2:511-7. https://doi.org/10.1177/096032718300200307